In section Market Quotes

KYORIN Holdings Reports 69% Surge in Nine-Month Net Profit

KYORIN Holdings Inc. posted a significant increase in profitability for the nine months ended December 31, with net income climbing to ¥4.12 billion. The Tokyo-based pharmaceutical firm saw gains across its entire balance sheet, outperforming the ¥2.44 billion net profit recorded during the same period the previous year.

The group’s revenue rose to ¥92.46 billion, a steady climb from the ¥89.29 billion reported a year earlier. This growth in sales supported a sharp rise in operating profit, which reached ¥4.61 billion, up from ¥3.12 billion. The results indicate a period of strengthened operational efficiency for the company amid a competitive domestic market.

Strengthening Financial Position

According to the company’s latest filing, pretax profit reached ¥5.10 billion, while earnings per share jumped to ¥71.71, compared to ¥42.46 in the prior-year period. These figures, prepared under Japanese accounting standards, underscore a robust recovery in the company's bottom-line performance.

The financial highlights for the nine-month period include:

    • A net profit increase of nearly 70% year-over-year.
    • Operating profit growth exceeding ¥1.4 billion.
    • A significant expansion in earnings per share for shareholders.
Share:on TelegramXFacebook

Subscribe to our newsletter

Once a week — the best stories from our editors, no ads or push notifications. Delivered Sunday morning.

Comments (0)

Leave a comment

No comments yet. Be the first!